Welcome to our dedicated page for Acadia Healthcar news (Ticker: ACHC), a resource for investors and traders seeking the latest updates and insights on Acadia Healthcar stock.
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) is a behavioral healthcare company that operates a large network of inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, comprehensive treatment centers and outpatient clinics across the United States and Puerto Rico. This news page aggregates company-specific updates and disclosures that help investors and observers follow developments in Acadia’s behavioral healthcare operations and corporate activities.
News related to ACHC often includes quarterly earnings releases, updates to financial guidance, and details on revenue performance by service type, such as acute inpatient psychiatric facilities, specialty treatment facilities, comprehensive treatment centers and residential treatment centers. The company also issues news about capital expenditure plans, bed additions, and development activity, including the opening of new hospitals, expansions of existing facilities and the addition of new comprehensive treatment centers.
Acadia’s news flow features announcements about participation in healthcare and investor conferences hosted by firms such as J.P. Morgan, UBS and Jefferies, where members of senior management discuss strategy, capital allocation and operating performance. Press releases may also cover executive leadership changes, including appointments and transitions in key roles like the Chief Financial Officer and Chief Operating Officer, as well as statements from the company regarding its approach to shareholder value and governance.
Other notable news items can include updates on professional and general liability reserves, securities litigation settlements, and responses to public letters from shareholders who comment on strategy and governance. By reviewing the ACHC news feed on this page, users can monitor Acadia’s reported operating trends, strategic priorities, capital plans and governance developments over time.
Acadia Healthcare (NASDAQ: ACHC) has announced its participation in the Stephens Annual Investment Conference, taking place from November 19-21, 2024, in Nashville, Tennessee. The company will deliver a presentation on Wednesday, November 20, 2024, at 11:00 a.m. Eastern Time (10:00 a.m. Central Time).
The presentation will be accessible via a live webcast on Acadia Healthcare's website under the 'Investors' section. A replay of the presentation will remain available on the company's website for 30 days following the event.
Acadia Healthcare reported strong Q3 2024 results with revenue of $815.6 million, up 8.7% year-over-year. Same facility revenue increased 8.6%, driven by a 3.6% increase in revenue per patient day and 4.7% growth in patient days. Net income reached $68.1 million ($0.74 per share), while adjusted income was $84.1 million ($0.91 per share). Adjusted EBITDA grew 10.5% to $194.3 million. The company expanded its facilities, adding 15 beds and five new CTCs during Q3, now operating 164 CTCs across 32 states. Acadia updated its 2024 guidance, projecting revenue of $3.15-3.165 billion and adjusted EBITDA of $725-735 million.
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) has announced the acquisition of three opioid treatment program clinics in South Carolina. These clinics, formerly operated by Recovery Concepts, Recovery Concepts of the Carolina Upstate, and Clear Skye Treatment Center, will be rebranded as part of Acadia's Comprehensive Treatment Center (CTC) service line. The facilities, now named Clinton, Easley, and Ridgeland Comprehensive Treatment Centers, are Acadia's first CTCs in South Carolina and will offer care to all patients, including those covered by Medicaid.
This acquisition follows Acadia's recent expansion in North Carolina, bringing the Company's CTC division to 165 locations across 33 states, treating over 72,000 patients daily. The CTCs provide medication-assisted treatment programs combining behavioral therapy and medication to treat opioid use disorders, along with comprehensive support services including medical, counseling, vocational, and educational assistance.
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) has issued a statement regarding a government investigation. CEO Chris Hunter emphasized the company's commitment to providing high-quality care and compliance. Acadia is investing in new talent, technology, clinical protocols, and training to improve its services. The company has expanded its leadership team with new roles focused on quality, compliance, and medical oversight.
Acadia addressed recent media reports of troubling patient experiences, stating they are inconsistent with company policies. The company emphasized that patient care decisions are made by licensed physicians based on medical considerations, not business factors. Acadia has implemented several initiatives to improve care, including:
- Expanding organizational structure with new specialized roles
- Investing $100 million in technology for patient safety and care coordination
- Implementing new training programs for frontline caregivers
- Standardizing clinical protocols and oversight
These efforts have reportedly led to improved patient experience scores and high quality ratings in their opioid treatment programs.
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) announces that seven of its facilities have been named on Newsweek's list of America's Best Addiction Treatment Centers 2024. The recognized centers are located across five states: Arizona, California, North Carolina, Pennsylvania, and Tennessee. This recognition comes during National Recovery Month and underscores Acadia's commitment to providing high-quality behavioral health and addiction services.
The list, compiled in partnership with Statista, recognizes 400 providers across 25 states based on accreditation data, a national online reputation survey, and Google reviews. Acadia's CEO, Chris Hunter, emphasized the company's focus on expanding access to best-in-class care by enhancing safety, quality, and clinical excellence.
The Schall Law Firm announces an investigation into Acadia Healthcare Company, Inc. (NASDAQ:ACHC) for potential securities law violations. The probe follows a New York Times report published on September 1, 2024, titled 'How a Leading Chain of Psychiatric Hospitals Traps Patients.' The article alleges that Acadia has been luring patients into its facilities and holding them against their will, even when not medically necessary. This practice has reportedly occurred in at least 12 of the 19 states where Acadia operates psychiatric hospitals. The news caused Acadia's shares to fall by 4.5% on September 3, 2024. Shareholders who suffered losses are encouraged to participate in the investigation.
Methodist Jennie Edmundson Hospital and Acadia Healthcare Company (ACHC) have broken ground on a new 96-bed behavioral health hospital in Council Bluffs, Iowa. The facility, named Methodist Jennie Edmundson Behavioral Health, is set to open in 2026 and will serve western Iowa and eastern Nebraska residents. The hospital will include 24 beds dedicated to children and adolescents and provide intensive outpatient services.
This joint venture aims to address a significant shortfall of over 300 inpatient behavioral health beds in Iowa and Nebraska. The state-of-the-art facility will focus on treating acute symptoms of mental health and substance use disorders, utilizing the latest technology and resources. The project demonstrates Methodist and Acadia's commitment to expanding access to high-quality behavioral health services in the region.
Acadia Healthcare Company (NASDAQ: ACHC) reported strong financial results for Q2 2024. Revenue increased 8.8% to $796.0 million, with same facility revenue up 8.3%. Net income reached $78.5 million, or $0.85 per diluted share. Adjusted EBITDA grew 7.6% to $187.6 million. The company added 37 beds to existing facilities and opened a new 100-bed hospital in Arizona.
Acadia updated its 2024 guidance, projecting revenue of $3.180 to $3.225 billion and adjusted EBITDA of $735 to $765 million. The company plans to add approximately 1,200 beds in 2024 and open four additional inpatient facilities in H2. With a strong financial position and strategic growth initiatives, Acadia aims to address the increasing demand for behavioral health services across the United States.
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) has announced the release date for its second quarter 2024 earnings report. The company will disclose its financial results on Wednesday, July 31, 2024, after the market closes. Following the release, Acadia will host a conference call with institutional investors and analysts on Thursday, August 1, 2024, at 9:00 a.m. ET. Interested parties can access a live broadcast of the conference call through the 'Investors' section of Acadia's website at www.acadiahealthcare.com. The webcast will remain available for 30 days after the call.
Acadia Healthcare (NASDAQ: ACHC) celebrated the 'Every Bite A Battle' program at its Timberline Knolls Residential Treatment Center in Lemont, Illinois. This initiative highlights the success stories of alumnae overcoming eating disorders, anxiety, depression, and trauma through transformative portraits. The campaign underscores the complex nature of eating disorders and the daily victories over related mental health challenges. Heather Seiler, an alumna, shared her journey of overcoming her struggles with the support of professionals and loved ones. Acadia Healthcare's Chief Marketing Officer, Mark Palmenter, emphasized that the project aligns with Acadia's mission to 'Lead Care with Light' and aims to inspire others facing similar challenges.